152
Participants
Start Date
October 15, 2018
Primary Completion Date
March 20, 2020
Study Completion Date
March 20, 2020
Live Attenuated Influenza Vaccine (LAIV)
1 dose, 0.2 mL, intranasal administration
Inactivated Influenza Vaccine (IIV)
1 dose, 0.5 mL, intramuscular administration
Duke University Medical Center, Durham
Vanderbilt University Medical Center, Nashville
Cincinnati Children's Hospital Medical Center, Cincinnati
Collaborators (1)
Centers for Disease Control and Prevention
FED
Duke University
OTHER
Children's Hospital Medical Center, Cincinnati
OTHER
Vanderbilt University Medical Center
OTHER